Helius Medical Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Helius Medical Technologies generated cash of -$10,416,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,077,000 last year. Net change in cash is therefore -$9,367,000.
Cash Flow
| 2014 | -348.69K | 0 | 364.44K |
|---|---|---|---|
| 2015 | -6.32M | -378K | 7.48M |
| 2016 | -7.88M | 378B | 7.99M |
| 2017 | -19.32M | -190K | 22.21M |
| 2018 | -19.62M | -440K | 40.02M |
| 2019 | -20.99M | -769K | 1.65M |
| 2020 | -11.73M | -9K | 9.63M |
| 2021 | -13.38M | -56K | 21.12M |
| 2022 | -14.31M | -11K | 17.86M |
| 2023 | -10.41M | -29K | 1.07M |
HSDT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.54M | 11.00M | 3.33M | 5.45M | 25.58M | 5.56M | 2.66M | 2.64M | 15.96K | 217 |
Operating activities | ||||||||||
Net income | -8.85M | -14.07M | -18.13M | -14.13M | -9.78M | -28.62M | -28.02M | -12.04M | -8.89M | -1.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 162K | 255K | 312K | 482K | 191K | 59K | 17K | 0 | 0 | 0 |
Stock-based compensation expense | 1.62M | 2.25M | 4.25M | 2.52M | 4.69M | 0 | 1.81M | 1.46M | 1.39M | 807.15K |
| Deferred income tax benefit | 1.62M | 2.25M | 4.25M | 2.52M | 4.69M | 0 | 1.81M | 1.46M | 1.39M | 807.15K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -291K | -9K | 30K | -4K | -438K | 429K | -479K | 174K | -8.94K | 0 |
Inventories | 137K | -111K | -87K | 4K | -206K | -392K | 0 | 0 | -110.87K | 0 |
Accounts payable | -103K | -418K | 369K | -635K | -1.11M | -1.08M | 1.31M | 345K | 979.04K | 210.08K |
Cash generated by operating activities | -10.41M | -14.31M | -13.38M | -11.73M | -20.99M | -19.62M | -19.32M | -7.88M | -6.32M | -348.69K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -378K | 0 |
Investments In Property Plant And Equipment | -29K | -17K | -56K | -70K | -353K | -440K | -190K | 0 | 0 | 0 |
Acquisitions Net | 0 | 6K | 0 | 61K | -416K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -29K | -11K | -56K | -9K | -769K | -440K | -190K | 378B | -378K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 500K | 18.64M | 21.12M | 10.65M | 1.68M | 38.52M | 20.87M | 7.90M | 7.77M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -323K | 0 | 0 | 0 | 0 | 2M | -2.23K |
Cash used in financing activities | 1.07M | 17.86M | 21.12M | 9.63M | 1.65M | 40.02M | 22.21M | 7.99M | 7.48M | 364.44K |
Net Change In Cash | -9.36M | 3.54M | 7.67M | -2.12M | -20.12M | 20.02M | 2.89M | 25K | 402.92K | 15.75K |
Cash at end of period | 5.18M | 14.54M | 11.00M | 3.33M | 5.45M | 25.58M | 5.56M | 2.66M | 418.89K | 15.96K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |